Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.

Wang C, Raldow AC, Nickols NG, Nguyen PL, Spratt DE, Dess RT, Yu JB, King CR, Chu FI, Chamie K, Litwin MS, Saigal CS, Reiter RE, Liu ST, Rettig MB, Chang AJ, Steinberg ML, Kupelian PA, Kishan AU.

Eur Urol Oncol. 2019 Feb 1. pii: S2588-9311(19)30007-0. doi: 10.1016/j.euo.2019.01.006. [Epub ahead of print]

PMID:
31411981
2.

Multi-institutional Analysis of Prostate-Specific Antigen Kinetics Following Stereotactic Body Radiotherapy (SBRT).

Jiang NY, Dang AT, Yuan Y, Chu FI, Shabsovich D, King CR, Collins SP, Aghdam N, Suy S, Mantz CA, Miszczyk L, Napieralska A, Namysl-Kaletka A, Bagshaw H, Prionas N, Buyyounouski MK, Jackson WC, Spratt DE, Nickols NG, Steinberg ML, Kupelian PA, Kishan AU.

Int J Radiat Oncol Biol Phys. 2019 Jul 2. pii: S0360-3016(19)33427-3. doi: 10.1016/j.ijrobp.2019.06.2539. [Epub ahead of print]

PMID:
31276777
3.

Fbxo41 Promotes Disassembly of Neuronal Primary Cilia.

King CR, A A Quadros AR, Chazeau A, Saarloos I, van der Graaf AJ, Verhage M, Toonen RF.

Sci Rep. 2019 Jun 3;9(1):8179. doi: 10.1038/s41598-019-44589-2.

4.

First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology.

Kang JJ, Reiter RE, Steinberg ML, King CR.

Eur Urol Oncol. 2018 Oct;1(5):378-385. doi: 10.1016/j.euo.2018.07.008. Epub 2018 Aug 22.

PMID:
31158076
5.

Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.

Yuan Y, Aghdam N, King CR, Fuller DB, Weng J, Chu FI, Mardirossian G, Patel A, Nickols NG, Kupelian PA, Steinberg ML, Collins SP, Kishan AU.

Int J Radiat Oncol Biol Phys. 2019 May 17. pii: S0360-3016(19)30727-8. doi: 10.1016/j.ijrobp.2019.05.014. [Epub ahead of print]

PMID:
31108142
7.

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.

Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C Jr, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.

Eur Urol. 2019 Apr 13. pii: S0302-2838(19)30208-8. doi: 10.1016/j.eururo.2019.03.022. [Epub ahead of print]

PMID:
30992160
8.

Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate.

Lee SM, Plieskatt J, Krishnan S, Raina M, Harishchandra R, King CR.

Protein Expr Purif. 2019 Aug;160:56-65. doi: 10.1016/j.pep.2019.04.001. Epub 2019 Apr 10.

9.

Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT.

Lubin DJ, Holden SB, Rettig MB, Reiter RE, King CR, Lee JM, Wallace DW, Calais J.

Clin Nucl Med. 2019 May;44(5):e353-e356. doi: 10.1097/RLU.0000000000002499.

PMID:
30789399
10.

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.

Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR.

JAMA Netw Open. 2019 Feb 1;2(2):e188006. doi: 10.1001/jamanetworkopen.2018.8006.

11.

Intravenous acetaminophen vs saline in perioperative analgesia with laparoscopic hysterectomy.

Rindos NB, Mansuria SM, Ecker AM, Stuparich MA, King CR.

Am J Obstet Gynecol. 2019 Apr;220(4):373.e1-373.e8. doi: 10.1016/j.ajog.2019.01.212. Epub 2019 Jan 22.

PMID:
30682359
12.

Early Postoperative Actigraphy Poorly Predicts Hypoactive Delirium.

Maybrier HR, King CR, Crawford AE, Mickle AM, Emmert DA, Wildes TS, Avidan MS, Palanca BJA; ENGAGES Study Investigators.

J Clin Sleep Med. 2019 Jan 15;15(1):79-87. doi: 10.5664/jcsm.7576.

13.

Selective C-H Functionalization of Methane and Ethane by a Molecular SbV Complex.

Koppaka A, Park SH, Hashiguchi BG, Gunsalus NJ, King CR, Konnick MM, Ess DH, Periana RA.

Angew Chem Int Ed Engl. 2019 Feb 18;58(8):2241-2245. doi: 10.1002/anie.201809159. Epub 2019 Jan 21.

PMID:
30589173
14.

Cancer overturned: Endometrioma mimicking granulosa cell tumor and the importance of FOXL2 analysis.

Rosen ER, Kushner DM, Mahajan AM, King CR.

Gynecol Oncol Rep. 2018 Nov 22;27:8-10. doi: 10.1016/j.gore.2018.11.006. eCollection 2019 Feb.

15.

The Transcriptional Repressor BS69 is a Conserved Target of the E1A Proteins from Several Human Adenovirus Species.

Zhang A, Tessier TM, Galpin KJC, King CR, Gameiro SF, Anderson WW, Yousef AF, Qin WT, Li SSC, Mymryk JS.

Viruses. 2018 Nov 22;10(12). pii: E662. doi: 10.3390/v10120662.

16.

Observed to expected 30-day mortality as a benchmark for transcatheter aortic valve replacement.

Henn MC, Zajarias A, Quader N, Sintek M, Lasala JM, Koogler K, Damiano MS, Kachroo P, Miller DC, King CR, Melby SJ, Moon MR, Damiano RJ Jr, Maniar HS.

J Thorac Cardiovasc Surg. 2018 Jul 27. pii: S0022-5223(18)32031-2. doi: 10.1016/j.jtcvs.2018.06.097. [Epub ahead of print]

PMID:
30454980
17.

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45.

Kundu P, Semesi A, Jore MM, Morin MJ, Price VL, Liang A, Li J, Miura K, Sauerwein RW, King CR, Julien JP.

Nat Commun. 2018 Oct 26;9(1):4458. doi: 10.1038/s41467-018-06742-9.

18.

Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis.

Kishan AU, Wang X, Seiferheld W, Collette L, Sandler KA, Sandler HM, Bolla M, Maingon P, De Reijke T, Hanks GE, Nickols NG, Rettig M, Drakaki A, Reiter RE, Spratt DE, Kupelian PA, Steinberg ML, King CR.

JAMA Oncol. 2019 Jan 1;5(1):91-96. doi: 10.1001/jamaoncol.2018.3732.

PMID:
30326032
19.

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes.

Huang WC, Deng B, Lin C, Carter KA, Geng J, Razi A, He X, Chitgupi U, Federizon J, Sun B, Long CA, Ortega J, Dutta S, King CR, Miura K, Lee SM, Lovell JF.

Nat Nanotechnol. 2018 Dec;13(12):1174-1181. doi: 10.1038/s41565-018-0271-3. Epub 2018 Oct 8.

20.

Optimal Treatment for High-Risk Prostate Cancer-Reply.

Kishan AU, Cook RR, King CR.

JAMA. 2018 Jul 24;320(4):405. doi: 10.1001/jama.2018.6721. No abstract available.

PMID:
30043055
21.

Malaria Vaccines: Recent Advances and New Horizons.

Draper SJ, Sack BK, King CR, Nielsen CM, Rayner JC, Higgins MK, Long CA, Seder RA.

Cell Host Microbe. 2018 Jul 11;24(1):43-56. doi: 10.1016/j.chom.2018.06.008. Review.

22.

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.

Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):883-888. doi: 10.1016/j.ijrobp.2018.03.060. Epub 2018 Apr 5.

PMID:
29976500
23.

Peptide data on the disulfide bond analysis of baculovirus produced Pfs25 by LC-MSMS.

Lee SM, Plieskatt JL, King CR.

Data Brief. 2018 Mar 12;18:209-233. doi: 10.1016/j.dib.2018.03.034. eCollection 2018 Jun.

24.

Decreasing recurrent bowel obstructions, improving quality of life with physiotherapy: Controlled study.

Rice AD, Patterson K, Reed ED, Wurn BF, Robles K, Klingenberg B, Weinstock LB, Pratt JS, King CR, Wurn LJ.

World J Gastroenterol. 2018 May 21;24(19):2108-2119. doi: 10.3748/wjg.v24.i19.2108.

25.

Hacking the Cell: Network Intrusion and Exploitation by Adenovirus E1A.

King CR, Zhang A, Tessier TM, Gameiro SF, Mymryk JS.

MBio. 2018 May 1;9(3). pii: e00390-18. doi: 10.1128/mBio.00390-18. Review.

26.

'I'm Black and I'm Proud': A Majority Ecological Context Protects Affective Aspects of Black Identity Under Stereotype Threat.

Oliver A, Andemeskel G, King CR, Wallace L, McDougal S, Monteiro KP, Ben-Zeev A.

Race Soc Probl. 2017 Dec;9(4):313-320. doi: 10.1007/s12552-017-9216-y. Epub 2017 Sep 27.

27.

Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG.

J Nucl Med. 2018 Nov;59(11):1714-1721. doi: 10.2967/jnumed.118.209387. Epub 2018 Apr 13.

28.

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.

Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR.

JAMA. 2018 Mar 6;319(9):896-905. doi: 10.1001/jama.2018.0587.

29.

Mimicry of Cellular A Kinase-Anchoring Proteins Is a Conserved and Critical Function of E1A across Various Human Adenovirus Species.

King CR, Gameiro SF, Tessier TM, Zhang A, Mymryk JS.

J Virol. 2018 Mar 28;92(8). pii: e01902-17. doi: 10.1128/JVI.01902-17. Print 2018 Apr 15.

30.

Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate.

Lee SM, Plieskatt J, King CR.

Anal Biochem. 2018 Feb 1;542:20-23. doi: 10.1016/j.ab.2017.11.009. Epub 2017 Nov 21.

31.

Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25.

Scally SW, McLeod B, Bosch A, Miura K, Liang Q, Carroll S, Reponen S, Nguyen N, Giladi E, Rämisch S, Yusibov V, Bradley A, Lemiale F, Schief WR, Emerling D, Kellam P, King CR, Julien JP.

Nat Commun. 2017 Nov 16;8(1):1568. doi: 10.1038/s41467-017-01924-3.

32.

Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein.

Oyen D, Torres JL, Wille-Reece U, Ockenhouse CF, Emerling D, Glanville J, Volkmuth W, Flores-Garcia Y, Zavala F, Ward AB, King CR, Wilson IA.

Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):E10438-E10445. doi: 10.1073/pnas.1715812114. Epub 2017 Nov 14. Erratum in: Proc Natl Acad Sci U S A. 2018 Jun 11;:.

33.

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG.

J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9.

34.

Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study.

Kishan AU, Cheng EM, Schmidt E, Saigal C, Reiter RE, Kupelian PA, Steinberg ML, King CR.

JCO Clin Cancer Inform. 2017 Nov;1:1-6. doi: 10.1200/CCI.17.00046.

35.

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.

Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodríguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple BD, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS.

JAMA. 2017 Sep 26;318(12):1115-1124. doi: 10.1001/jama.2017.11469. Erratum in: JAMA. 2018 Mar 27;319(12 ):1281.

36.

Profiling the Targets of Protective CD8+ T Cell Responses to Infection.

Bruder JT, Chen P, Ekberg G, Smith EC, Lazarski CA, Myers BA, Bolton J, Sedegah M, Villasante E, Richie TL, King CR, Aguiar JC, Doolan DL, Brough DE.

Mol Ther Methods Clin Dev. 2017 Aug 18;7:20-31. doi: 10.1016/j.omtm.2017.08.003. eCollection 2017 Dec 15.

37.

Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.

Hegde JV, Demanes DJ, Veruttipong D, Raince J, Park SJ, Raman SS, Nickols NG, King CR, Kishan AU, Steinberg ML, Kamrava M.

Brachytherapy. 2017 Nov - Dec;16(6):1106-1112. doi: 10.1016/j.brachy.2017.07.008. Epub 2017 Aug 12.

PMID:
28807747
38.

N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate.

Lee SM, Wu CK, Plieskatt JL, Miura K, Hickey JM, King CR.

Clin Vaccine Immunol. 2017 Oct 5;24(10). pii: e00140-17. doi: 10.1128/CVI.00140-17. Print 2017 Oct.

39.

External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.

Wang C, Kishan AU, Kamrava M, Steinberg ML, King CR.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1045-1052. doi: 10.1016/j.ijrobp.2017.03.040. Epub 2017 Mar 31.

PMID:
28721887
40.

In Reply to Scott.

Shaverdian N, Steinberg ML, King CR.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):217. doi: 10.1016/j.ijrobp.2017.02.012. No abstract available.

PMID:
28586966
41.

Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer.

Kishan AU, King CR.

Semin Radiat Oncol. 2017 Jul;27(3):268-278. doi: 10.1016/j.semradonc.2017.02.006. Epub 2017 Feb 22. Review.

PMID:
28577834
42.

Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.

Hegde JV, Veruttipong D, Said JW, Reiter RE, Steinberg ML, King CR, Kishan AU.

Urology. 2017 Sep;107:171-177. doi: 10.1016/j.urology.2017.05.028. Epub 2017 May 25.

PMID:
28552819
43.

Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer.

Shaverdian N, Kishan AU, Veruttipong D, Demanes DJ, Kupelian P, McCloskey S, Steinberg ML, King CR.

Am J Clin Oncol. 2018 Sep;41(9):898-904. doi: 10.1097/COC.0000000000000387.

PMID:
28537990
44.

Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone Metastases.

Walling AM, Beron PJ, Kaprealian T, Kupelian PA, Wenger NS, McCloskey SA, King CR, Steinberg M.

J Palliat Med. 2017 Feb 23. doi: 10.1089/jpm.2016.0339. [Epub ahead of print]

45.

Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer.

Kishan AU, Duchesne G, Wang PC, Rwigema JM, Kishan AU, Saigal C, Rettig M, Steinberg ML, King CR.

Am J Clin Oncol. 2018 Aug;41(8):739-746. doi: 10.1097/COC.0000000000000381.

PMID:
28301348
46.

Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancer.

Wang C, King CR, Kamrava M, Iwamoto KS, Chen AM, Low D, Kupelian PA, Steinberg ML.

Radiother Oncol. 2017 Apr;123(1):133-138. doi: 10.1016/j.radonc.2017.01.009. Epub 2017 Feb 7.

PMID:
28187996
47.

Treatment trends for patients with brain metastases: Does practice reflect the data?

Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, Steinberg ML, Lee P.

Cancer. 2017 Jun 15;123(12):2274-2282. doi: 10.1002/cncr.30607. Epub 2017 Feb 8.

48.

Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.

Shaverdian N, Verruttipong D, Wang PC, Kishan AU, Demanes DJ, McCloskey S, Kupelian P, Steinberg ML, King CR.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):516-525. doi: 10.1016/j.ijrobp.2016.11.007. Epub 2016 Nov 24.

PMID:
28126301
50.

Urinary toxicity after stereotactic body radiotherapy: The boy who cried wolf?

Kishan AU, Kupelian PA, Steinberg ML, King CR.

Cancer. 2017 Feb 1;123(3):531-532. doi: 10.1002/cncr.30432. Epub 2016 Dec 20. No abstract available.

Supplemental Content

Support Center